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a b s t r a c t
The concept of patient navigation was first introduced in 1989 by the American Cancer Society and was
first implemented in 1990 by Dr. Harold Freeman in Harlem, NY. The role of a patient navigator (PN) is to
coordinate care between the care team, the patient, and their family while also providing social support.
In the last 30 years, patient navigation in oncological care has expanded internationally and has been
shown to significantly improve patient care experience, especially in the United States cancer care system. Like oncology care, patients who require epilepsy care face socioeconomic and healthcare system
barriers and are at significant risk of morbidity and mortality if their care needs are not met. Although
shortcomings in epilepsy care are longstanding, the COVID-19 pandemic has exacerbated these issues
as both patients and providers have reported significant delays in care secondary to the pandemic.
Prior to the pandemic, preliminary studies had shown the potential efficacy of patient navigation in
improving epilepsy care. Considering the evidence that such programs are helpful for severely disadvantaged cancer patients and in enhancing epilepsy care, we believe that professional societies should support and encourage PN programs for coordinated and comprehensive care for patients with epilepsy.
Ó 2020 Elsevier Inc. All rights reserved.

1. Patient navigation in oncological care
The concept of patient navigation was first introduced in 1989
following the American Cancer Society ‘‘National Hearings on Cancer in the Poor.” After hearing testimony from low-income United
States (US) citizens of various races and ethnicities diagnosed with
cancer, the committee concluded that these patients face greater
barriers in seeking and obtaining cancer care than their more privileged counterparts. Further, these barriers often actively prevented them from obtaining cancer care and led to poor
outcomes and greater suffering [1]. After confronting late-stage
breast cancers in his low-income and minority patients in Harlem,
NY, Dr. Harold Freeman initiated the first patient navigation program in the US in 1990. This program focused on ensuring the continuity of care from diagnosis to treatment and beyond for patients
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with cancer, with a patient navigator (PN) from the community
tasked with guiding patients and their families through social, economic, financial, cultural, bureaucratic, and psychological barriers
that often hindered their access to healthcare services [1,2].
In the last 30 years, patient navigation programs to assist cancer
patients have been implemented in the United States, Australia,
Canada, Sweden, Denmark, and Brazil. In the modern US cancer
care system, there is evidence that PNs improve the care experience for patients and their families [3–5]. While evidence proving
the benefits of PNs in improving cancer outcomes is mixed, the
impact on cancer care quality is greatest when they are targeted
to populations with severe socioeconomic disparities and for diseases where there is poor adherence to guidelines [6]. This
describes perfectly the situation of epilepsy care in the United
States. Here, we make the argument that there is an urgent need
to improve epilepsy care, due to the socioeconomic and healthcare
system barriers to care faced by the patients, as well as the welldocumented risks faced by patients who do not receive highquality care. The PN is one of the few interventions that might
change this situation and improve outcomes.

https://doi.org/10.1016/j.yebeh.2020.107530
1525-5050/Ó 2020 Elsevier Inc. All rights reserved.
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2. Patient navigation in epilepsy care

life years (QALYs). However, despite the demonstrable efficacy of
epilepsy surgery, patients, on average, wait between 17 and
23 years from seizure onset to surgery [19–21]. Even then epilepsy
surgery remains underutilized, with many patients never receiving
the benefits of surgery [22]. Efforts to decrease the time to surgery,
such as those interventions introduced by Drees et al., would not
only decrease the amount of time patients are at risk for mortality
and SUDEP, but also potentially increase survival, seizure-free survival, and quality of life.

The severe socioeconomic disadvantages of patients with medically refractory epilepsy make this patient population an attractive target for placement of PNs. Studies have found non-white
and socioeconomically disadvantaged individuals are disproportionately affected by epilepsy, and yet they are less likely to receive
anti-seizure medications, less likely to undergo surgical treatment,
and less likely to receive specialized care [7–13]. Nathan et al. eloquently attributes these disparities to 6 key factors using the acronym FACETS – 1) Fear of treatment, 2) Access to care, 3)
Communication barriers, 4) Education, 5) Trust between patient
and physician, and 6) Social support [9]. They also propose possible
interventions such as ‘‘patient education and empowerment,”
social workers, patient-provider racial concordance, community
engagement, and strict adherence to post-procedure follow-up
with a social worker or community contact to target and mitigate
these disparities [9]. Similarly, Pieters et al. reported testimonies of
epilepsy patient caretakers of the trials and tribulations of navigating the road to epilepsy surgery. These caretakers often found the
journey to epilepsy surgery to be arduous, lonely, and distressing,
especially considering the complexity of epilepsy and the need to
make urgent decisions in limited time periods. Like Nathan et al.,
Pieters et al. also proposed mechanisms to alleviate these struggles, specifically, social support for patients and caretakers, shared
decision making between providers, patients, and caretakers, and
the ‘‘need for one professional who champions and navigates care”
[14]. Without explicitly using the terms ‘‘patient navigator” or
‘‘nurse navigator,” Nathan et al. and Pieters et al. advocate for an
individual who can educate and empower patients, provide postprocedural follow-up, provide social support, facilitate shared decision making, and serve as the point of contact to champion and
navigate care.
Despite the lack of national guidelines for PNs in epilepsy care, a
few researchers have sought to implement such programs in their
own practice. Drees et al. from the University of Colorado studied
the effects of certain interventions, including increasing the number of patient care conferences, enabling faster access to intracarotid amobarbital testing, adding a dedicated epilepsy surgery
clinic, and hiring a nurse navigator (i.e., PN) to coordinate presurgical evaluation of epilepsy patients. They found that these interventions led to a decrease in time to epilepsy surgery by almost
100 days and almost tripled the rate of annual epilepsy surgeries.
Although they were unable to identify the effect of each individual
intervention, they found that the addition of a nurse navigator,
specifically, added extra benefit, especially in significantly reducing the time to surgery as compared to the baseline group [15].
The effects of the interventions introduced by Drees et al. are
especially significant when considering the mortality of untreated
or undertreated epilepsy. Studies have found that overall mortality
in patients with epilepsy is 1.6–3.0 times greater when compared
to the general population. Those mortality numbers increase to
2.2 to 6.5-fold greater in patients with epilepsy of known etiology
when compared to the general population [16]. The most common
epilepsy-related cause of death is Sudden Unexplained Death in
EPilepsy (SUDEP). Sudden Unexplained Death in EPilepsy affects
between 1.5 and 5.9 per 1000 person-years in patients with refractory epilepsy and 6.3–9.3 among those who are candidates for epilepsy surgery [17]. Sudden Unexplained Death in EPilepsy risk is
increased with lack of seizure freedom, nocturnal seizures, and as
few as one generalized tonic-clonic seizure a year [18]. The risks
of SUDEP, as well as mortality from seizure-related trauma, drowning and status epilepticus, can be significantly reduced with epilepsy surgery: in a 35-year-old patient, an average anterior
temporal lobectomy adds 5 years of life and 7.5 quality-adjusted

3. The COVID-19 pandemic and epilepsy care
While these shortcomings in epilepsy care are longstanding, the
COVID-19 pandemic has exacerbated these gaps, hindering both
diagnosis and access to treatment. Although efforts have been
made to accommodate epilepsy concerns with telemedicine, these
efforts are limited by many factors. Patients of lower socioeconomic status may not have access to telemedicine and struggle
to maintain reliable lines of communication [23]. Furthermore,
despite the serious risks of poorly controlled epilepsy, many neurologists and specialty nurses from Comprehensive Epilepsy Centers were redeployed to acute care COVID units, and may be
again [23]. For example, during the height of the pandemic, we
had a patient whose generalized convulsive seizure frequency
increased from 1 every 3–4 months to 1 a week, associated with
end of life of his vagus nerve stimulator internal pulse generator.
There was a delay in delivery of prompt care for this patient which
may have been averted, had there been adequate resources allocated to help him navigate the system and receive proper, timely
care for his intractable epilepsy. In one survey of pediatric epilepsy
clinicians, 97.8% reported a change in practice due to the pandemic, described as either a reduction of non-life-threatening cases
or complete suspension of epilepsy surgery [24]. These acute interruptions in inpatient epilepsy care and outpatient follow-up not
only lead to increased risk of patient attrition now, but also after
the pandemic, when the backlog generated by pandemic leads to
further delays in time-critical care. A PN, whose job it is to ensure
appropriate, triaged follow-up and maintain those lines of communication with the patient, could help mitigate patient attrition
rates from this pandemic.
Similarly to other problems in America, the COVID-19 pandemic
has led to an acute exacerbation of the chronic problems affecting
epilepsy care. Those communities affected most by epilepsy are the
least likely to receive appropriate care and patients often wait
years before receiving surgery, placing them at increased risk of
morbidity and mortality. Physicians and healthcare workers have
the responsibility to advocate and effect changes in care. Starting
in 2015, the American College of Surgeons (ACoS) Commission on
Cancer required a ‘‘patient navigation process” that is ‘‘established
to address healthcare disparities and barriers to care for patients”
as part of certification. Epilepsy advocates should demand the
same.
4. Conclusion
Considering the evidence of such programs for severely disadvantaged patients with cancer and preliminary evidence in
enhancing epilepsy care, we believe that professional societies
should support and encourage patient navigation programs for
coordinated and comprehensive care for epilepsy patients. Such
programs are supported by the International League Against Epilepsy [25]. We propose that the National Association of Epilepsy
Centers (NAEC), American Academy of Neurologists (AAN), American Epilepsy Society (AES), and Epilepsy Foundations include rec2
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ommendations for patient navigation programs in their own recognition of Comprehensive Epilepsy Centers and in the requirements
for accreditation process.
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